Choosing and evaluating randomisation methods in clinical trials: a qualitative study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Choosing and evaluating randomisation methods in clinical trials: a qualitative study ; volume:25 ; number:1 ; day:20 ; month:3 ; year:2024 ; pages:1-11 ; date:12.2024
Trials ; 25, Heft 1 (20.3.2024), 1-11, 12.2024
- Creator
-
Bruce, Cydney L.
Iflaifel, Mais
Montgomery, Alan
Ogollah, Reuben
Sprange, Kirsty
Partlett, Christopher
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-024-08005-z
- URN
-
urn:nbn:de:101:1-2405212121345.847055083049
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bruce, Cydney L.
- Iflaifel, Mais
- Montgomery, Alan
- Ogollah, Reuben
- Sprange, Kirsty
- Partlett, Christopher
- SpringerLink (Online service)
Other Objects (12)
A re-randomisation design for clinical trials
Seven myths of randomisation in clinical trials
Choosing sensitivity analyses for randomised trials: principles
Rapid centralised randomisation in emergency setting trials using a smartphone
The use of randomisation-based efficacy estimators in non-inferiority trials
Use of randomisation in clinical trials: a survey of UK practice
Correction to: Picking and Choosing Among Phase I Trials
Independence estimators for re-randomisation trials in multi-episode settings: a simulation study
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Exploring patients’ treatment journeys following randomisation in mental health trials to improve future trial conduct: a synthesis of multiple qualitative data sets
Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis
No Choosing
A re-randomisation design for clinical trials
Seven myths of randomisation in clinical trials
Choosing sensitivity analyses for randomised trials: principles
Rapid centralised randomisation in emergency setting trials using a smartphone
The use of randomisation-based efficacy estimators in non-inferiority trials
Use of randomisation in clinical trials: a survey of UK practice
Correction to: Picking and Choosing Among Phase I Trials
Independence estimators for re-randomisation trials in multi-episode settings: a simulation study
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Exploring patients’ treatment journeys following randomisation in mental health trials to improve future trial conduct: a synthesis of multiple qualitative data sets
Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis
No Choosing
A re-randomisation design for clinical trials
Seven myths of randomisation in clinical trials
Choosing sensitivity analyses for randomised trials: principles
Rapid centralised randomisation in emergency setting trials using a smartphone
The use of randomisation-based efficacy estimators in non-inferiority trials
Use of randomisation in clinical trials: a survey of UK practice
Correction to: Picking and Choosing Among Phase I Trials
Independence estimators for re-randomisation trials in multi-episode settings: a simulation study
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Exploring patients’ treatment journeys following randomisation in mental health trials to improve future trial conduct: a synthesis of multiple qualitative data sets
Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis